Search Within

Neil Jayendra Shah

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (7)
  3. Research Letter (1)
Groups
  1. Department of Medicine (25)
  2. Genitourinary Oncology Service (25)
  3. Population Sciences Research Program (25)
  4. Solid Tumor Oncology Division (25)
  5. Hematologic Malignancies, Division of (23)
  6. Weinberg Fellows (23)

More Groups

People
  1. Ritesh Kotecha (23)
  2. Maria Carlo (22)
  3. Martin Voss (21)
  4. Robert Motzer (21)
  5. Darren Feldman (20)
  6. Chung-Han Lee (19)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (5)
  5. 2021 (3)
  6. 2020 (1)
Publications
  1. Journal of Clinical Oncology (17)
  2. European Urology (2)
  3. European Urology Oncology (2)
  4. Cancer (1)
  5. Cancer Research (1)
  6. Current Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. Elsevier BV (2)
  3. Elsevier Science, Inc. (2)
  4. American Association for Cancer Research (1)
  5. Multimed Inc (1)
  6. Wiley Blackwell (1)

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; McHugh, D. J.; Dadoun, C.; Knezevic, A.; Carlo, M. I.; Feld, E.; Shapnik, N.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing
    Journal Article

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Reisz, P. A.; Lenis, A. T.; Mehta, N. N.; Khurram, A.; Joseph, V.; Mandelker, D.; more...
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Real-time data quality assurance analysis for real-world, pan-cancer data
    Meeting Abstract

    Brown, S.; Lee, J.; Pillai, A.; Gandhi, F.; Bahadur, N.; Barton, L.; Chan, K.; Niederhausern, A.; Nichols, C.; Philip, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save